-
Je něco špatně v tomto záznamu ?
Antifungal activity of silver nanoparticles against Candida spp
A. Panáček, M. Kolář, R. Večeřová, R. Prucek, J. Soukupová, V. Kryštof, P. Hamal, R. Zbořil, L. Kvítek
Jazyk angličtina Země Velká Británie
Typ dokumentu práce podpořená grantem
- MeSH
- antifungální látky farmakologie MeSH
- buněčné linie MeSH
- Candida účinky léků MeSH
- kovové nanočástice terapeutické užití MeSH
- lidé MeSH
- stříbro farmakologie MeSH
- viabilita buněk účinky léků MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- práce podpořená grantem MeSH
The antifungal activity of the silver nanoparticles (NPs) prepared by the modified Tollens process was evaluated for pathogenic Candida spp. by means of the determination of the minimum inhibitory concentration (MIC), minimum fungicidal concentration (MFC), and the time-dependency of yeasts growth inhibition. Simultaneously the cytotoxicity of the silver NPs to human fibroblasts was determined. The silver NPs exhibited inhibitory effect against the tested yeasts at the concentration as low as 0.21 mg/L of Ag. The inhibitory effect of silver NPs was enhanced through their stabilization and the lowest MIC equal to 0.05 mg/L was determined for silver NPs stabilized by sodium dodecyl sulfate against Candida albicans II. The obtained MICs of the silver NPs and especially of the stabilized silver NPs were comparable and in some cases even better than MICs of the conventional antifungal agents determined by E-test. The silver NPs effectively inhibited the growth of the tested yeasts at the concentrations below their cytotoxic limit against the tested human fibroblasts determined at a concentration equal to 30 mg/L of Ag. In contrast, ionic silver inhibited the growth of the tested yeasts at the concentrations comparable to the cytotoxic level (approx. 1mg/L) of ionic silver against the tested human fibroblasts.
Department of Physical Chemistry Faculty of Science Palacky University Olomouc 771 46 Czech Republic
Citace poskytuje Crossref.org
- 000
- 02738naa 2200397 a 4500
- 001
- bmc11022366
- 003
- CZ-PrNML
- 005
- 20221005143525.0
- 008
- 110729s2009 xxk e Eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.biomaterials.2009.07.065 $2 doi
- 035 __
- $a (PubMed)19698988
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Panáček, Aleš, $d 1978- $7 jx20070503016
- 245 10
- $a Antifungal activity of silver nanoparticles against Candida spp / $c A. Panáček, M. Kolář, R. Večeřová, R. Prucek, J. Soukupová, V. Kryštof, P. Hamal, R. Zbořil, L. Kvítek
- 314 __
- $a Department of Physical Chemistry, Faculty of Science, Palacky University, Olomouc 771 46, Czech Republic.
- 520 9_
- $a The antifungal activity of the silver nanoparticles (NPs) prepared by the modified Tollens process was evaluated for pathogenic Candida spp. by means of the determination of the minimum inhibitory concentration (MIC), minimum fungicidal concentration (MFC), and the time-dependency of yeasts growth inhibition. Simultaneously the cytotoxicity of the silver NPs to human fibroblasts was determined. The silver NPs exhibited inhibitory effect against the tested yeasts at the concentration as low as 0.21 mg/L of Ag. The inhibitory effect of silver NPs was enhanced through their stabilization and the lowest MIC equal to 0.05 mg/L was determined for silver NPs stabilized by sodium dodecyl sulfate against Candida albicans II. The obtained MICs of the silver NPs and especially of the stabilized silver NPs were comparable and in some cases even better than MICs of the conventional antifungal agents determined by E-test. The silver NPs effectively inhibited the growth of the tested yeasts at the concentrations below their cytotoxic limit against the tested human fibroblasts determined at a concentration equal to 30 mg/L of Ag. In contrast, ionic silver inhibited the growth of the tested yeasts at the concentrations comparable to the cytotoxic level (approx. 1mg/L) of ionic silver against the tested human fibroblasts.
- 590 __
- $a bohemika - dle Pubmed
- 650 _2
- $a antifungální látky $x farmakologie $7 D000935
- 650 _2
- $a Candida $x účinky léků $7 D002175
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a viabilita buněk $x účinky léků $7 D002470
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kovové nanočástice $x terapeutické užití $7 D053768
- 650 _2
- $a stříbro $x farmakologie $7 D012834
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kolář, Milan, $d 1964- $7 jn20010310083
- 700 1_
- $a Večeřová, Renata $7 xx0114985
- 700 1#
- $a Prucek, Robert. $7 _AN053488
- 700 1#
- $a Soukupová, Jana. $7 _AN056459
- 700 1_
- $a Kryštof, Vladimír, $d 1973- $7 xx0097406
- 700 1_
- $a Hamal, Petr $7 xx0060595
- 700 1_
- $a Zbořil, Radek, $d 1973- $7 xx0140669
- 700 1_
- $a Kvítek, Libor, $d 1960- $7 kup19960000054713
- 773 0_
- $t Biomaterials $w MED00000753 $g Roč. 30, č. 31 (2009), s. 6333-6340
- 910 __
- $a ABA008 $b x $y 2 $z 0
- 990 __
- $a 20110801151025 $b ABA008
- 991 __
- $a 20221005143520 $b ABA008
- 999 __
- $a ok $b bmc $g 881751 $s 732286
- BAS __
- $a 3
- BMC __
- $a 2009 $x MED00000753 $b 30 $c 31 $d 6333-6340 $m Biomaterials $n Biomaterials
- LZP __
- $a 2011-4B09/jvme